Barriers to inhaled gene therapy of obstructive lung diseases: A review - Wikidata - wikimedia - TriplyDB

Barriers to inhaled gene therapy of obstructive lung diseases: A review

Barriers to inhaled gene therapy of obstructive lung diseases: A review

http://www.wikidata.org/entity/Q29248141

about

Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.The Mucus Barrier to Inhaled Gene Therapy.Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties.Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse.Protein nanocages that penetrate airway mucus and tumor tissue.Lessons learned from lung and liver in-vivo gene therapy: implications for the future

P2860

Q28076132-1F765857-F6E7-42E3-B5FA-5F05BE444125 Q30844270-985A9EC0-6E4C-44ED-A0E4-A4A873AB2F45 Q38959100-24D821FE-9578-4703-AEA1-26AE828DBBAB Q44832157-E0D0F6C8-5DC4-43EC-88CF-4804793F33A6 Q47151105-89A9463F-4F81-48F2-9EC8-6B7D760EEDCD Q47885456-38383EF0-FFE6-43E0-9DD8-1851B66AC043 Q57163666-E2E6F086-A5DA-4319-AE3B-B2E3DEE19043

P2860

Barriers to inhaled gene therapy of obstructive lung diseases: A review

http://www.wikidata.org/entity/Q29248141

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@ast

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@en

type

label

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@ast

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@en

prefLabel

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@ast

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@en

P1433

Q29248141-0AE76DAF-70E8-4A1C-BD39-0A58945C999B

P1476

Q29248141-FB40B609-4A54-4F85-9654-5E86782EB594

P2093

Q29248141-17B41ECC-FFA3-4430-9293-E15131315D6C

Q29248141-4458A9FF-1401-4E9D-8CF4-31033689D10C

Q29248141-68B98986-76DE-46DE-8158-32E4F6839D8A

P2860

Q29248141-001C78DB-CD1E-489D-B44F-9E1620118367

Q29248141-0085F338-F7DE-4A8C-9BB4-D8EEBEB0D084

Q29248141-00FB17DF-C0C3-4224-8BB7-61DEE8571253

Q29248141-00FFDF04-B934-442E-BCCA-37950DDCD4E7

Q29248141-01B023C6-A55D-4C1A-86C3-4B55FCD86C00

Q29248141-02ADD925-B286-4061-A518-C8F7F646EA7E

Q29248141-02E07E9C-520B-4E66-83C6-1E121AE3ACE9

Q29248141-03DEFA91-01D8-4456-A4D7-24F4FD8BB848

Q29248141-04C68144-64C0-4958-A5CF-A47D4A2BCCA6

Q29248141-062F48CB-7019-43C8-9BA4-91A0C66E7644

P304

Q29248141-98EB73D2-CB89-4E4F-B1DA-62B0573B44CE

P31

Q29248141-4CD96619-58E8-487A-8A1A-8806292ACDC0

P3181

Q29248141-F3817B8F-7907-4E37-9993-808A540A768E

P356

Q29248141-2C84FD04-D386-412D-A4B9-0C50B36D2A13

P407

Q29248141-35DF52D2-B80B-4EFF-B6D3-52F1332A6DB4

P478

Q29248141-D8A191ED-8E54-4877-9764-85DE56B22CEC

P50

Q29248141-AAF94E63-3DD2-407F-8C9A-4FE41DD4A82A

P577

Q29248141-8ED44072-2B03-4C69-9CE7-A16B41BF42B5

P698

Q29248141-2B80DBED-9EDD-4916-BD6E-92C78A32B161

P921

Q29248141-3B4FCCEA-ADD9-4ED2-A35A-817E90A92021

P932

Q29248141-7197FB48-0771-42BE-811E-7B2D898CEFDA

P3181

P356

J.JCONREL.2016.05.031

P1433

Journal of Controlled Release

P1476

Barriers to inhaled gene therapy of obstructive lung diseases: A review

@en

P2093

Jung Soo Suk

http://www.w3.org/2001/XMLSchema#string

Justin Hanes

http://www.w3.org/2001/XMLSchema#string

Namho Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Correcting the cystic fibrosis disease mutant, A455E CFTR

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia.

Maxi K+ channel mediates regulatory volume decrease response in a human bronchial epithelial cell line

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

Altering the tropism of lentiviral vectors through pseudotyping.

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

Directed evolution of adeno-associated virus to an infectious respiratory virus

The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model

P304

465-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3441732

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JCONREL.2016.05.031

http://www.w3.org/2001/XMLSchema#string

P407

P478

240

http://www.w3.org/2001/XMLSchema#string

P50

Gregg A. Duncan

P577

2016-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27196742

http://www.w3.org/2001/XMLSchema#string

P921

P932

5064827

http://www.w3.org/2001/XMLSchema#string